Keith Gottesdiener

Keith Gottesdiener

Former Chief Executive OfficeratPrime Medicine· In proxies 2022–2025

Pay in FY2025Prime Medicine stock +18.8% the same year

Keith Gottesdiener was paid $2.2M in FY2025 (Dec). Prime Medicine stock rose 18.8% that year.

Pay$100 in the stock at the end of FY24 → $119
Pay is from the Summary Compensation Table of each Prime Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Prime MedicinePublic company · 4 yr
    • Former Chief Executive Officer2022 – Present · 4 yrStock in role -65%
  2. Intercept Pharmaceuticals, Inc.Public company · 7 yr
    • Director2017 – 2024 · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?